Hepatology
The VLVbio K18 assays in the field of Hepatology
Find more information about your disease of interest below
General Information

M30 Apoptosense® ELISA M65® ELISA M65 EpiDeath® ELISA M30 Apoptosense® ELISA M65® ELISA M65 EpiDeath® ELISA M30 Apoptosense® ELISA M65® ELISA M65 EpiDeath® ELISA M30 Apoptosense® ELISA M65® ELISA M65 EpiDeath® ELISA M30 Apoptosense® ELISA M65® ELISA M65 EpiDeath® ELISA
Non-alcoholic Steatohepatitis
NASH is a progressive and serious form of Non-alcoholic Fatty Liver Disease (NAFLD), and has during the last couple of decades become one of the most common causes of liver disease globally and a public health problem.
Alcoholic Steatohepatitis
Alcoholic Steatohepatitis (ASH, or AH) is a liver condition under Alcoholic Liver Disease (ALD), caused by chronic alcohol abuse.
Drug-Induced Liver Injury
Drug-Induced Liver Injury (DILI) is one of the most common reason for acute liver failure and a condition that may require liver transplantation and in some cases even has fatal outcomes.
Hepatitis C
An estimated 3% of the world’s population — more than 170 million people — are infected by the hepatitis C virus (HCV). About 70% of infections become chronic: a condition that is associated with developing end stage liver disease such as cirrhosis and hepatocellular carcinoma (HCC).